CNTB · Connect Biopharma Holdings Ltd
$2.28
-0.18 (-7.32%)
At close · Aug 20
Market Cap
$155.86M
Shares
62.97M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.28
Open$2.48
Day$2.26–2.62
52W close$1.32–3.69
Avg vol 30d403K
Short int2.1M · 3.3% float · 8.0d
Short vol43%
Last earningsJun 30, 2022
DataMar 2021–Aug 2026
Filing10-Q · Aug 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 12, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Very Bullish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−7%
below
Price vs 50-day avg
+2%
above
RSI (14)
50
neutral
MACD trend
Positive
52-week position
41%
mid-range
Momentum
relative strength
1-month return
+4%
trailing
6-month return
−8%
trailing
YTD return
−19%
this year
Relative strength
−19%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+38% holders QoQ · +24 funds added
Insider flow
Accumulating
Net +$371.6K over 90 days · 0% sells
Short interest
Falling
3.27% of float · ▼ -0.1% MoM · 8.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
55 holders — near 1-yr high, broad support
Squeeze score
59
elevated · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−257%
Y/Y
Free cash flow
$-51.6M
Balance sheet
$38.3M
net cash
Quant / Vol
risk profile
Volatility
92%
annualized · 1-yr
Max drawdown
−47%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−7%
Bearish
Price vs 50-day avg
+2%
Bullish
RSI (14)
50
Neutral
MACD trend
Positive
Bullish
52-week position
41%
Neutral
Market signals — smart money & positioning
Bullish · 4 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
+38% holders QoQ · +24 funds added
Insider flow
Accumulating
Net +$371.6K over 90 days · 0% sells
Short interest
Falling
3.27% of float · ▼ -0.1% MoM · 8.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
55 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $2 · 41%
Range high $4
vs 200-day avg -7%
vs 50-day avg +2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNTB
this stock
Connect Biopharma Holdings Ltd
|
$155.86M | -19.1% | -99.8% | — | 3.3% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
55
- % held
- 22.1%
- Net QoQ
- +870.3K sh
- Top holder
- Ikarian Capital, LLC
Held
Float
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNTB | -10.2% | +3.6% | -7.7% | +12.9% | -19.2% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -8.3% | +0.3% | -18.9% | +10.8% | -31.0% |
Key facts
CIK
1835268
CUSIP
G23549101
13F (30d)
52 filings
52 filers
Visit website
Investor relations